share_log

4: Statement of changes in beneficial ownership of securities-Director SAPIRSTEIN JAMES

4: Statement of changes in beneficial ownership of securities-Director SAPIRSTEIN JAMES

4：持股变动声明-董事 SAPIRSTEIN JAMES
美股SEC公告 ·  07/19 09:36

Moomoo AI 已提取核心信息

James Sapirstein, a reporting person for ZyVersa Therapeutics, Inc. [ZVSA], engaged in a transaction involving the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. Consequently, the number of shares held by Sapirstein after the transaction remains unknown. This information is critical for investors to understand the potential impact on their investment and the confidence level of insiders in the company's performance.
James Sapirstein, a reporting person for ZyVersa Therapeutics, Inc. [ZVSA], engaged in a transaction involving the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. Consequently, the number of shares held by Sapirstein after the transaction remains unknown. This information is critical for investors to understand the potential impact on their investment and the confidence level of insiders in the company's performance.
2023年5月24日，ZyVersa Therapeutics Inc.（ZVSA）的报告人James Sapirstein参与了一笔公司股票的交易。该公告未披露交易的具体细节，包括股份的数量、性质、交易价格和股份的总价值。因此，交易后Sapirstein持有的股份数量仍然是未知的。这些信息对于投资者了解投资潜力以及内部人对公司表现的信心水平至关重要。
2023年5月24日，ZyVersa Therapeutics Inc.（ZVSA）的报告人James Sapirstein参与了一笔公司股票的交易。该公告未披露交易的具体细节，包括股份的数量、性质、交易价格和股份的总价值。因此，交易后Sapirstein持有的股份数量仍然是未知的。这些信息对于投资者了解投资潜力以及内部人对公司表现的信心水平至关重要。
有用
没用

该公告为独立文件：

独立文件1

独立文件2

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    热议
    美股
    股票代码最新价涨跌幅

    暂无数据

    资讯热榜
    更新时间